
After obtaining the EU’s CE mark for the Ascope 5 Broncho device in May, medtech firm Ambu can now also launch in the US, according to a Tuesday press release.
The US Food and Drug Administration (FDA) has approved the single-use bronchoscope portfolio, which the firm says has more advanced imaging features due to a new high-resolution camera chip.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app